Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (8): 91-97.doi: 10.6040/j.issn.1671-7554.0.2022.0417
Previous Articles Next Articles
JIANG Ziqing1, ZENG Yanping1,2, JI Xiaodong2, ZUO Junling2
CLC Number:
[1] 朱蕾, 魏沙沙, 张云桂, 等. 艾滋病合并马尔尼菲篮状菌病临床及药敏研究[J]. 皮肤病与性病, 2019, 41(2): 166-169. ZHU Lei, WEI Shasha, ZHANG Yungui, et al. Clinical and susceptibility study of AIDS complicated with Talaromycosis [J]. Journal of Dermatology and Venereology, 2019, 41(2): 166-169. [2] He LY, Mei X, Lu S, et al. Talaromyces marneffei infection in non-HIV-infected patients in mainland China [J]. Mycoses, 2021, 64(10): 1170-1176. [3] Li YY, Lin ZY, Shi X, et al. Retrospective analysis of 15 cases of Penicillium marneffei infection in HIV-positive and HIV-negative patients [J]. Microb Pathog, 2017, 105: 321-325. doi: 10.1016/j.micpath.2017.01.026. [4] Wang PL, Chen YF, Xu H, et al. Acute disseminated Talaromyces marneffei in an immunocompetent patient [J]. Mycopathologia, 2017, 182(7/8): 751-754. [5] Zhang ZX, Tao FX, Li YN, et al. Disseminated Penicillium marneffei infection recurrence in a non-acquired immune deficiency syndrome patient: a case report [J]. Mol Clin Oncol, 2016, 5(6): 829-831. [6] Vanittanakom N, Cooper CR Jr, Fisher MC, et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects [J]. Clin Microbiol Rev, 2006, 19(1): 95-110. [7] Qiu Y, Liao HF, Zhang JQ, et al. Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study [J]. BMC Infect Dis, 2015, 15: 525. doi: 10.1186/s12879-015-1243-y. [8] Cao CW, Xi LY, Chaturvedi V. Talaromycosis(penicilliosis)due to Talaromyces(Penicillium)marneffei: insights into the clinical trends of a major fungal disease 60 Years after the discovery of the pathogen [J]. Mycopathologia, 2019, 184(6): 709-720. [9] Vanittanakom N, Cooper CR, Jr Fisher MC, et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects [J]. Clin Microbiol Rev, 2006, 19(1): 95-110. [10] Ning CY, Lai JZ, Wei WD, et al. Accuracy of rapid diagnosis of Talaromyces marneffei: a systematic review and meta-analysis [J]. PLoS One, 2018, 13(4): e0195569. [11] Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Diagnostic laboratory immunology for talaromycosis(penicilliosis): review from the bench-top techniques to the point-of-care testing[J]. Diagn Microbiol Infect Dis, 2020, 96(3):114959. [12] Li HN, Gao H, Meng H, et al. Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing [J]. Front Cell Infect Microbiol, 2018, 8: 205. doi: 10.3389/fcimb.2018.00205. [13] 李学青, 王丽娜, 张俐, 等. 肺泡灌洗液二代基因测序对儿童重症肺炎病原学诊断应用观察[J]. 中国实用儿科杂志, 2019, 34(6): 513-516. LI Xueqing, WANG Lina, ZHANG Li, et al. Application of alveolar lavage fluid mNGS in the etiological diagnosis of children with severe pneumonia [J]. Chinese Journal of Practical Pediatrics, 2019, 34(6): 513-516. [14] 张淋, 洪城, 孟新科, 等. 宏基因组学第二代测序技术对比传统实验室微生物培养在脓毒症病原学诊断中的优势[J]. 中国急救医学, 2022, 42(2): 114-120. ZHANG Lin, HONG Cheng, MENG Xinke, et al. The advantages of metagenomic next - generation sequencing compared with traditional laboratory microbial culture in the pathogen diagnosis of sepsis [J]. Chinese Journal of Critical Care Medicine, 2022, 42(2): 114-120. [15] Larsson M, Nguyen LHT, Wertheim HF, et al. Clinical characteristics and outcome of penicillium marneffei infection among HIV-infected patients in northern Vietnam [J]. AIDS Res Ther, 2012, 9(1): 24. [16] Ouyang YY, Cai SQ, Liang H, et al. Administration of voriconazole in disseminated Talaromyces(Penicillium)marneffei infection: a retrospective study [J]. Mycopathologia, 2017, 182(5/6): 569-575. [17] “十三五”国家科技重大专项艾滋病机会性感染课题组.艾滋病合并马尔尼菲篮状菌病临床诊疗的专家共识[J]. 西南大学学报(自然科学版), 2020, 42(7): 61-75. AIDS-Associated Opportunistic Infections Research Group of the National Science and Technology Major Project of China During the 13th Five Year Plan Period. Expert consensus on the diagnosis and treatment of talaromycosis in AIDS patients in China [J]. Journal of Southwest University(Natural Science Edition), 2020, 42(7): 61-75. [18] Campo M, Berliner N. Hemophagocytic lymphohistiocytosis in adults [J]. Hematol Oncol Clin North Am, 2015, 29(5): 915-925. [19] Chellapandian D. Hemophagocytic lymphohistiocytosis: lessons learned from the dark side [J]. Immunol Allergy clin North Am, 2020, 40(3): 485-497. [20] Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment[J]. J pediatr, 2013, 163(5):1253-1259. [21] Athale J. Challenges in identifying hemophagocytic lymphohistiocytosis in the ICU [J]. Crit Care Med, 2020, 48(4): 599-600. [22] 周海丰. 慢性乙型肝炎、乙肝肝硬化及原发性肝癌患者血清CEA、AFP、CA125和CA199水平检测分析[J]. 临床合理用药杂志, 2020, 13(23): 124-126. [23] 蔡锋, 朱运海, 赵杰, 等. 急性梗阻性化脓性胆管炎与糖类抗原199和血小板计数变化的关系[J]. 中华实验外科杂志, 2021, 38(8): 1563-1566. CAI Feng, ZHU Yunhai, ZHAO Jie, et al. Correlation between carbohydrate antigen 199, platelet count and acute obstructive suppurative cholangitis [J]. Chinese Journal of Experimental Surgery, 2021, 38(8): 1563-1566. [24] Robert M, Jarlier M, Gourgou S, et al. Retrospective analysis of CA19-9 decrease in patients with metastatic pancreatic carcinoma treated with FOLFIRINOX or gemcitabine in a randomized phase III study(ACCORD11/PRODIGE4)[J]. Oncology, 2017, 93(6): 367-376. [25] 唐伟萍, 钟楠, 陈志未, 等. 噬血细胞综合征患者肝功能损害的临床特点分析[J]. 中国实验血液学杂志, 2019, 27(4): 1297-1304. TANG Weiping, ZHONG Nan, CHEN Zhiwei, et al. Clinical characteristics of liver dysfunction in patients with hemophagocytic syndrome [J]. Journal of Experimental Hematology, 2019, 27(4):1297-1304. [26] Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis [J]. Am J Hematol, 2015, 90(3): 220-224. [27] Delavigne K, Bérard E, Bertoli S, et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy [J]. Haematologica, 2014, 99(3): 474-480. [28] Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide [J]. Br J Haematol, 2015, 168(1): 63-68. [29] 王新凯, 王晶石, 王旖旎, 等. 噬血细胞综合征患者红细胞寿命的检测及其对患者贫血的影响分析[J]. 中国实验血液学杂志, 2020, 28(2): 652-656. WANG Xinkai, WANG Jingshi, WANG Yini, et al. Detection of erythrocyte life and analysis of its effect on the anemia in patients with hemophagocytic syndrome [J]. Journal of Experimental Hematology, 2020, 28(2): 652-656. [30] 王澎, 翟丽慧, 范洪伟, 等. 9例非HIV感染患者马尔尼菲蓝状菌播散感染的回顾性分析报告[J]. 中国真菌学杂志, 2016, 11(5): 261-264. WANG Peng, ZHAI Lihui, FAN Hongwei, et al. Retrospective analysis of the clinical and laboratory features of 9 disseminated Talaromyces marneffei cases in non-HIV patients [J]. Chinese Journal of Mycology,2016, 11(5): 261-264. [31] Jiang J, Meng S, Huang S, et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China:a retrospective cohort study [J]. Clin Microbiol Infect, 2019, 25(2): 233-241. [32] Knaak C, Schuster FS, Nyvlt P, et al. Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis[J]. Crit Care Med, 2020, 48(11): e1137-e1146. [33] Pan M, Qiu Y, Zeng W, et al. Talaromycosis-associated secondary hemophagocytic lymphohistiocytosis in nine human immunodeficiency virus-negative patients: a multicenter retrospective study [J]. Infect Drug Resist, 2019, 12: 3807-3816. doi: 10.2147/IDR.S232713. |
[1] | CHE Guowei. It is necessary for enhanced recovery after surgery to keep pace with the times [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 17-22. |
[2] | JIN Faguang. Expatiation of the diagnosis and treatment of benign central airway stenosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 7-13. |
[3] | MIAO Chunxia, LI Hanhan, ZHUO Lang, WANG Wenhai, JIANG Jinxing, ZHENG Juan, HUANG Wenhao, ZHAO Shihong. Residents’ choices of medical treatment institutions based on hierarchical diagnosis and treatment system in Xuzhou City [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 82-87. |
|